Atlas Capital Advisors LLC Bio N Tech Se Transaction History
Atlas Capital Advisors LLC
- $770 Billion
- Q2 2024
A detailed history of Atlas Capital Advisors LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 53 shares of BNTX stock, worth $6,237. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53
Previous 53
-0.0%
Holding current value
$6,237
Previous $4.89 Million
12.89%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
323Shares Held
38.7MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$974 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$564 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$515 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$344 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$223 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.6B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...